Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and growth potential. Learn why BMY stock is a solid ...
Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...
A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedicines routinely aggrandize their AI ...
Discover how MultiCare Health System in Tacoma, WA reduced their pharmacy spend by 24% in a few years through data analytics and a strategic partnership.
The Boston textbook publisher has acquired Visible Body, which specializes in making digital biomedical images for ...
Bristol-Myers Squibb beat Q4 earnings expectations, but the stock fell due to lowered 2025 revenue guidance and patent ...
Continuous manufacturing (CM) has become a contentious topic in the modern pharmaceutical lexicon, driven by divergent ...
The widely used FAST acronym remains the best tool for helping bystanders recognize stroke symptoms, despite efforts to expand it to BE-FAST.
In a study appearing in Nature Chemistry, UC Davis researchers report the successful total synthesis of ibogaine, ibogaine analogues and related compounds from pyridine — a relatively inexpensive and ...
The Kobe University start-up Photo-on-Demand Chemical Co. Ltd. demonstrated that it can produce methane from sewage to refine ...
A new, comprehensive map of all the genes essential for blood infections in Plasmodium knowlesi (P. knowlesi), a parasite ...
The IPO boom of 2024 is far from over. With 2,000 IPOs expected in the next two years (as per AIBI), India’s equity market is ...